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suggests that sporotrichosis is more
prevalent in tropical environments
with relatively cool temperatures and
high humidity such the Peruvian
Andes (9), northwest India (5), south-
western Vietnam (8), and in Laos in
the Plain of Jars. If this environmental
association is correct, sporotrichosis
may occur more extensively in the
cooler humid areas of Asia, such as
the highlands of China, Laos,
Vietnam, and Burma. Sporotrichosis
can disseminate in HIV-infected
patients, and this syndrome may
increase as the prevalence of HIV
infection rises in these areas.
With 73% of the Lao population
living on <US$2/day (10) and one
accessible microbiologic culture labo-
ratory in Laos, PCR is not an available
local routine diagnostic technique. We
were fortunate to have access to an
overseas diagnostic facility, which
allowed confirmation of the clinical
diagnosis before the patient received a
prolonged course of a drug with
adverse effects and drug interactions.
Diagnosis by histopathologic
examination and culture may be diffi-
cult, and identifying laboratories in
different regions of the subtropics and
tropics with an interest in diagnosis of
sporotrichoid lesions and the capabili-
ty to perform culture and PCR would
facilitate the diagnosis and awareness
of this disease. Itraconazole, which has
become the drug of choice for lympho-
cutaneous sporotrichosis, is expensive.
Saturated solution of potassium iodide
is an inexpensive alternative and
appears to be effective, although
adverse effects occur frequently (3,4).
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West Nile Virus
Antibodies in
Colombian Horses
To the Editor: West Nile Virus
(WNV) is rapidly spreading in the
Western Hemisphere (1). We report
the first evidence for WNV transmis-
sion in South America.
WNV is serologically related to
the Japanese encephalitis complex of
flaviviruses (Flaviviridae), which
includes Saint Louis encephalitis
virus (SLEV) (in North and South
America), Japanese encephalitis virus
(Asia), and Murray Valley encephali-
tis virus (Australia) (2). Because of
antigenic cross-reactivity within this
complex, WNV serologic diagnosis
requires highly specific assays, such
as the plaque-reduction neutralization
test (PRNT) (3). We used PRNT to
evaluate serum collected from 130
healthy equines (horses and donkeys)
in Colombia, where WNV had not
been previously reported. These
equines were sampled between
September 15 and October 29, 2004,
in the northern departments of
Córdoba and Sucre in the Caribbean
region of Colombia. Samples were
heat-inactivated and titrated by PRNT
for antibodies to WNV, SLEV, and 3
other South American flaviviruses:
Rocio, Ilhéus, and Bussuquara.
Twelve specimens (9%) from 10 dif-
ferent premises tested positive for
WNV (Table). None of these animals
had been vaccinated against WNV or
had traveled outside of the region. An
equine immunoglobulin (Ig) M-cap-
ture enzyme-linked immunosorbent
assay (ELISA) that used WNV anti-
gen detected anti-WNV IgM in 2 of
the 12 specimens, which indicated
that some of these infections were rel-
atively recent (probably within 3
months of sampling). The positive
findings in both Córdoba and Sucre
were corroborated by a WNV-specific
blocking ELISA (4). Numerous other
samples exhibited flavivirus reactivity
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in the neutralization and blocking
ELISA assays, mostly because of
SLEV. Complete test results from
these horses, as well as from
Colombian cattle and chickens, will
be presented elsewhere.
These serologic data should be
considered indirect evidence of WNV
activity in Colombia. We encourage
Colombian human and animal health
authorities to enhance surveillance for
human, equine, and avian disease
attributable to WNV. Efforts are need-
ed to isolate the virus or detect specif-
ic viral RNA to confirm this finding
and to identify vectors and vertebrate
hosts involved in WNV transmission
in Colombia.
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Wild Poliovirus
Type 1, Central
African Republic 
To the Editor: In this article we
summarize the investigation and
response to the reemergence of wild
poliovirus (WPV) type 1 in the
Central African Republic (CAR) in
2003. Since 2000, reported annual
routine vaccination coverage with >3
doses of oral polio vaccine (OPV) has
been very low in CAR (<50%);
National Immunization Days have
been conducted every year since
1996, except in 2002 (1). 
From December 2003 to November
2004, the active acute flaccid paralysis
surveillance system reported 112 cases
of acute flaccid paralysis suspected to
be polio-myelitis and 4 deaths (case-
fatality ratio 4%). Fecal samples were
collected and sent to the Institut
Pasteur de Bangui. WPV type 1
(WPV1) was isolated in 30 cases
(27%), vaccine polioviruses in 15
cases (5 type 1, 5 type 2, and 6 type 3)
(13%), and nonpolio enteroviruses in
18 cases (16%). Epidemiologic inves-
tigations showed that 97% of patients
with poliomyelitis received <3 doses
of OPV and 93% of patients were <5
years of age. Isolates were sent to the
National Institute for Virology in
Johannesburg, South Africa, for
sequencing. All viruses were type 1
and could be traced to common ances-
tral strains that circulate in disease-
endemic reservoirs shared by northern
Nigeria and southern Niger (WEAF-B
genotype). The first importation
occurred in Chad in August 2003 from
northeastern Nigeria, and the outbreak
spread to the adjacent countries of
Cameroon in October 2003 and the
CAR in December 2003. 
In CAR, the first case occurred in a
19-month-old child living in Ndjoh
village north of Bossembélé in Ombela
M’Poko. A special mission by the
World Health Organization/ CAR offi-
cer determined that the child had not
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